Overview
Jayashree Parekh is a Nuclear Medicine provider in Richmond, Virginia. Dr. Parekh is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Marginal Zone Lymphoma (MZL), and Muscle Invasive Bladder Cancer. Dr. Parekh is currently accepting new patients in some locations.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- POS
Locations
1001 E Leigh St, Richmond, VA 23298
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Parekh isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung NodulesDr. Parekh isExperienced. Learn about Lung Nodules.
- Marginal Zone Lymphoma (MZL)Dr. Parekh isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Muscle Invasive Bladder CancerDr. Parekh isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Parekh isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.